Description
This is a complex of laboratory tests and calculated indicators based on them, used for diagnosing and monitoring the liver condition in the presence of NASH, steatosis, and liver fibrosis/cirrhosis using a single standard blood sample:
• NashTest 2 assesses liver inflammation as a quantitative evaluation of steatohepatitis and prediction of liver disease outcome;
• SteatoTest 2 – assessment of liver steatosis;
• FibroTest – assessment of liver fibrosis, prediction of long-term mortality associated with liver disease;
• ActiTest for patients with chronic viral hepatitis C and B;
• AshTest for patients with alcoholic steatohepatitis (acute alcoholic hepatitis).
Clinicians require all diagnostic panels for making decisions on treatment and/or follow-up.
Period of execution
Within 7 days. The specified time does not include the day of biomaterial collection
Biomaterial type